186 related articles for article (PubMed ID: 33499015)
1. Identification of Tyrosinase Inhibitors and Their Structure-Activity Relationships via Evolutionary Chemical Binding Similarity and Structure-Based Methods.
Durai P; Ko YJ; Kim JC; Pan CH; Park K
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499015
[TBL] [Abstract][Full Text] [Related]
2. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives.
Karakaya G; Türe A; Ercan A; Öncül S; Aytemir MD
Bioorg Chem; 2019 Jul; 88():102950. PubMed ID: 31075740
[TBL] [Abstract][Full Text] [Related]
4. Novel virtual screening approach for the discovery of human tyrosinase inhibitors.
Ai N; Welsh WJ; Santhanam U; Hu H; Lyga J
PLoS One; 2014; 9(11):e112788. PubMed ID: 25426625
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.
Choi J; Lee YM; Jee JG
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283382
[TBL] [Abstract][Full Text] [Related]
6. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach.
Cardoso R; Valente R; Souza da Costa CH; da S Gonçalves Vianez JL; Santana da Costa K; de Molfetta FA; Nahum Alves C
Molecules; 2021 May; 26(10):. PubMed ID: 34066283
[TBL] [Abstract][Full Text] [Related]
8. 1,2,3-Triazole-based kojic acid analogs as potent tyrosinase inhibitors: Design, synthesis and biological evaluation.
Ashooriha M; Khoshneviszadeh M; Khoshneviszadeh M; Moradi SE; Rafiei A; Kardan M; Emami S
Bioorg Chem; 2019 Feb; 82():414-422. PubMed ID: 30428420
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and computational molecular docking simulation study of novel kojic acid derivatives as anti-tyrosinase and antioxidant agents.
Chen YM; Li C; Zhang WJ; Shi Y; Wen ZJ; Chen QX; Wang Q
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):990-998. PubMed ID: 31072148
[TBL] [Abstract][Full Text] [Related]
10. Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors.
Ashooriha M; Khoshneviszadeh M; Khoshneviszadeh M; Rafiei A; Kardan M; Yazdian-Robati R; Emami S
Eur J Med Chem; 2020 Sep; 201():112480. PubMed ID: 32652434
[TBL] [Abstract][Full Text] [Related]
11. Isobenzofuran-1(3H)-ones as new tyrosinase inhibitors: Biological activity and interaction studies by molecular docking and NMR.
Pires DAT; Guedes IA; Pereira WL; Teixeira RR; Dardenne LE; Nascimento CJ; Figueroa-Villar JD
Biochim Biophys Acta Proteins Proteom; 2021 Feb; 1869(2):140580. PubMed ID: 33278593
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-Site Blocking Combined with Optimization of Molecular Docking for Efficient Discovery of Potential Tyrosinase Specific Inhibitors from
Liu H; Zhu Y; Wang T; Qi J; Liu X
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314397
[TBL] [Abstract][Full Text] [Related]
13. Combined kinetic studies and computational analysis on kojic acid analogous as tyrosinase inhibitors.
Lima CR; Silva JR; de Tássia Carvalho Cardoso E; Silva EO; Lameira J; do Nascimento JL; do Socorro Barros Brasil D; Alves CN
Molecules; 2014 Jul; 19(7):9591-605. PubMed ID: 25004069
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors.
Vontzalidou A; Zoidis G; Chaita E; Makropoulou M; Aligiannis N; Lambrinidis G; Mikros E; Skaltsounis AL
Bioorg Med Chem Lett; 2012 Sep; 22(17):5523-6. PubMed ID: 22835872
[TBL] [Abstract][Full Text] [Related]
15. A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors.
Vittorio S; Seidel T; Germanò MP; Gitto R; Ielo L; Garon A; Rapisarda A; Pace V; Langer T; De Luca L
Mol Inform; 2020 Mar; 39(3):e1900054. PubMed ID: 31508903
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking studies of (1E,3E,5E)-1,6-Bis(substituted phenyl)hexa-1,3,5-triene and 1,4-Bis(substituted trans-styryl)benzene analogs as novel tyrosinase inhibitors.
Ha YM; Lee HJ; Park D; Jeong HO; Park JY; Park YJ; Lee KJ; Lee JY; Moon HR; Chung HY
Biol Pharm Bull; 2013; 36(1):55-65. PubMed ID: 23302637
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of aryl pyrazole via Suzuki coupling reaction, in vitro mushroom tyrosinase enzyme inhibition assay and in silico comparative molecular docking analysis with Kojic acid.
Channar PA; Saeed A; Larik FA; Batool B; Kalsoom S; Hasan MM; Erben MF; El-Seedi HR; Ali M; Ashraf Z
Bioorg Chem; 2018 Sep; 79():293-300. PubMed ID: 29793142
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the thujaplicins for inhibition of human tyrosinase.
Yoshimori A; Oyama T; Takahashi S; Abe H; Kamiya T; Abe T; Tanuma S
Bioorg Med Chem; 2014 Nov; 22(21):6193-200. PubMed ID: 25288494
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of kojic acid derivatives containing 1,2,4-triazole as potent tyrosinase inhibitors.
Xie W; Zhang J; Ma X; Yang W; Zhou Y; Tang X; Zou Y; Li H; He J; Xie S; Zhao Y; Liu F
Chem Biol Drug Des; 2015 Nov; 86(5):1087-92. PubMed ID: 25916324
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis.
Gultekin E; Bekircan O; Kolcuoğlu Y; Akdemir A
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100058. PubMed ID: 33900640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
